{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:08:49Z","timestamp":1747206529233,"version":"3.40.5"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OTT"],"DOI":"10.2147\/ott.s382501","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T23:31:25Z","timestamp":1659569485000},"page":"845-846","source":"Crossref","is-referenced-by-count":0,"title":["Antimetastatic Effect of Epigenetic Drugs, Hydralazine and Valproic Acid, in Ras-Transformed NIH 3T3 Cells [Corrigendum]"],"prefix":"10.2147","volume":"Volume 15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4896-4111","authenticated-orcid":true,"given":"Enrique","family":"P\u00e9rez-C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9592-8527","authenticated-orcid":true,"given":"Luc\u00eda","family":"Taja-Chayeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catalina","family":"Trejo-Becerril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Chanona-Vilchis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-5935","authenticated-orcid":true,"given":"Alma","family":"Ch\u00e1vez-Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guadalupe","family":"Dom\u00ednguez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6180-8036","authenticated-orcid":true,"given":"Elizabeth","family":"Langley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1220-5014","authenticated-orcid":true,"given":"Alejandro","family":"Garc\u00eda-Carranc\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Due\u00f1as-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,8]]},"container-title":["OncoTargets and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=82681","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=82681","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T23:31:25Z","timestamp":1659569485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/corrigendum-antimetastatic-effect-of-epigenetic-drugs-hydralazine-and--peer-reviewed-fulltext-article-OTT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ott.s382501","relation":{},"ISSN":["1178-6930"],"issn-type":[{"type":"electronic","value":"1178-6930"}],"subject":[],"published":{"date-parts":[[2022,8]]}}}